Previous 10 | Next 10 |
Hagens Berman, National Trial Attorneys, Encourages Assertio Holdings (ASRT) Investors with Substantial Losses to Contact Firm SAN FRANCISCO, CA / ACCESSWIRE / January 24, 2024 / Hagens Berman urges Assertio Holdings, Inc. (NASDAQ:ASRT) investors who suffered substantial losses to submit ...
SAN FRANCISCO, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Assertio Holdings, Inc. (NASDAQ: ASRT) investors who suffered substantial losses to submit your losses now . Class Period: Mar. 9, 2023 – Nov. 8, 2023 Lead Plaintiff Deadline: Mar. 5, 2024 Visi...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $25,000 investing in Assertio stock or options between March 9, 2023 and November 8, 2023 a...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $25,000 investing in Assertio stock or options between March 9, 2023 and November 8, 2023 a...
NEW YORK, NY / ACCESSWIRE / January 18, 2024 / Bernstein Liebhard LLP: Do you, or did you, own shares of Assertio Holdings, Inc. (NASDAQ:ASRT)? Did you purchase your shares between March 9, 2023 and November 8, 2023, inclusive? Did you lose money in your investment in Assertio Holdin...
Hagens Berman, National Trial Attorneys, Encourages Assertio Holdings (ASRT) Investors with Substantial Losses to Contact Firm San Francisco, California--(Newsfile Corp. - January 11, 2024) - Hagens Berman urges Assertio Holdings, Inc. (NASDAQ: ASRT) investors who suffered substantial losses t...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $25,000 investing in Assertio stock or options between March 9, 2023 and November 8, 2023 a...
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of all persons or entities who purchased or otherwise acquired Assertio Hol...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Assertio To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $25,000 investing in Assertio stock or options between March 9, 2023 and November 8, 2023 a...
BOSTON, Jan. 08, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed against Assertio Holdings, Inc. (NASDAQ: ASRT) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the firm to learn more about how they might recover those ...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...
LAKE FOREST, Ill., May 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that its Board of...